Comparative study of the effectiveness of transcatheter arterial chemotherapy with and without lipiodol in patients with intermediate-stage hepatocellular carcinoma

BACKGROUND: Transarterial chemoembolization (TACE) and transarterial chemoinfusion (TACI) are widely recommended in various clinical guidelines and have become standard treatments for patients with intermediate-stage hepatocellular carcinoma (HCC) who are not candidates for surgical resection. The aim of this study was to compare the effectiveness of transcatheter arterial chemotherapy with and without lipiodol in patients with intermediate-stage HCC.METHODS: An observational analytic study with a cross-sectional design was conducted, using medical records from patients treated between January 2022 and December 2023. Data were analyzed using SPSS software, with a P value of